Basilea Pharmaceutica Ag Stock Today
| BPMUF Stock | USD 44.45 3.70 9.08% |
Performance7 of 100
| Odds Of DistressOver 51
|
Basilea Pharmaceutica is trading at 44.45 as of the 19th of April 2024. This is a 9.08 percent increase since the beginning of the trading day. The stock's lowest day price was 44.45. Basilea Pharmaceutica has 51 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Basilea Pharmaceutica AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland. The company has 11.93 M outstanding shares. More on Basilea Pharmaceutica AG
Moving against Basilea Pink Sheet
| 0.78 | CSLLY | CSL | PairCorr |
| 0.62 | CMXHF | CSL Limited | PairCorr |
| 0.61 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.54 | ZTLLF | Zonetail | PairCorr |
| 0.45 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Basilea Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Basilea Pharmaceutica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Basilea Pharmaceutica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Ronald Scott |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Basilea Pharmaceutica AG [BPMUF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 626.06 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Basilea Pharmaceutica's market, we take the total number of its shares issued and multiply it by Basilea Pharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Basilea Pharmaceutica classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 11.93 M outstanding shares.
Basilea Pharmaceutica AG has accumulated about 140.74 M in cash with (32.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.89.
Check Basilea Pharmaceutica Probability Of Bankruptcy
Ownership AllocationBasilea Pharmaceutica retains a total of 11.93 Million outstanding shares. Basilea Pharmaceutica AG shows 3.07 percent of its outstanding shares held by insiders and 29.13 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Basilea Ownership Details
Basilea Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Basilea Pharmaceutica jumping above the current price in 90 days from now is near 1%. The Basilea Pharmaceutica AG probability density function shows the probability of Basilea Pharmaceutica pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Basilea Pharmaceutica has a beta of 0.1803 suggesting as returns on the market go up, Basilea Pharmaceutica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Basilea Pharmaceutica AG will be expected to be much smaller as well. Additionally, basilea Pharmaceutica AG has an alpha of 0.1127, implying that it can generate a 0.11 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Basilea Pharmaceutica to move above the current price in 90 days from now is near 1 (This Basilea Pharmaceutica AG probability density function shows the probability of Basilea Pink Sheet to fall within a particular range of prices over 90 days) .
Basilea Pharmaceutica Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Basilea Pharmaceutica market risk premium is the additional return an investor will receive from holding Basilea Pharmaceutica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Basilea Pharmaceutica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Basilea Pharmaceutica's alpha and beta are two of the key measurements used to evaluate Basilea Pharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.4359 | |||
| Standard Deviation | 1.5 | |||
| Variance | 2.25 | |||
| Risk Adjusted Performance | 0.0607 |
Basilea Stock Against Markets
Picking the right benchmark for Basilea Pharmaceutica pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Basilea Pharmaceutica pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Basilea Pharmaceutica is critical whether you are bullish or bearish towards Basilea Pharmaceutica AG at a given time. Please also check how Basilea Pharmaceutica's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Basilea Pharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Basilea Pharmaceutica Corporate Directors
Basilea Pharmaceutica corporate directors refer to members of a Basilea Pharmaceutica board of directors. The board of directors generally takes responsibility for the Basilea Pharmaceutica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Basilea Pharmaceutica's board members must vote for the resolution. The Basilea Pharmaceutica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Rinderknecht | Member of the Board of Directors | Profile | |
| Domenico Scala | Member of the Board of Directors | Profile | |
| Nicole Onetto | Member of the Board of Directors | Profile | |
| HansBeat Guertler | Member of the Board of Directors | Profile |
How to buy Basilea Pink Sheet?
Before investing in Basilea Pharmaceutica, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Basilea Pharmaceutica. To buy Basilea Pharmaceutica stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Basilea Pharmaceutica. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Basilea Pharmaceutica stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Basilea Pharmaceutica AG stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Basilea Pharmaceutica AG stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Basilea Pharmaceutica AG, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Basilea Pharmaceutica AG?
The danger of trading Basilea Pharmaceutica AG is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Basilea Pharmaceutica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Basilea Pharmaceutica. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Basilea Pharmaceutica is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Basilea Pharmaceutica AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Basilea Pink Sheet analysis
When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |